Urinary citrate and stone disease

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Citrate plays an important role in calcium oxalate stone formation. Hypocitraturia has now been found in topiramate therapy, bariatric surgery, and high-protein low-carbohydrate diet. Citrate indirectly reduces urinary saturation of stone-forming calcium salts by complexing calcium and reducing ionized calcium fraction in urine; its direct effect on nucleation, crystal growth, and agglomeration is minor or uncertain. Hypocitraturia can be readily corrected by potassium citrate treatment. This treatment also increases urinary pH. The physicochemical effects of increased urinary citrate and pH from potassium citrate treatment when critically examined by estimating urinary saturation of brushite and calcium oxalate reveal that potassium citrate treatment does not increase urinary saturation of brushite and more dramatically decreases the saturation of calcium oxalate.

Original languageEnglish (US)
Title of host publicationUrolithiasis: Basic Science and Clinical Practice
PublisherSpringer-Verlag London Ltd
Pages187-194
Number of pages8
ISBN (Print)9781447143871, 9781447143833
DOIs
Publication statusPublished - Jan 1 2012

    Fingerprint

Keywords

  • Atkins diet
  • Bariatric surgery
  • Brushite
  • Calcium oxalate
  • Physicochemical action of citrate
  • Potassium citrate
  • Topiramate
  • Urinary citrate

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pak, C. Y. C. (2012). Urinary citrate and stone disease. In Urolithiasis: Basic Science and Clinical Practice (pp. 187-194). Springer-Verlag London Ltd. https://doi.org/10.1007/978-1-4471-4387-1_22